Abstract
Objectives We aimed to improve understanding of the role of imaging in diagnosis of low back pain by determining the prevalence of age-related disc degeneration in asymptomatic and symptomatic subjects. Spinal MRIs of symptomatic and asymptomatic subjects were re-annotated onto the same objective grading system and prevalence of degenerative changes compared.
Methods In an exploratory cross-sectional study, we compared the prevalence of disc degeneration between two large groups of anonymised females, 30-80yrs, viz a symptomatic group with chronic back pain (724) and an asymptomatic (701) group. We used a verified automated MRI annotation system to re-annotate their spinal MRIs and report degeneration on the Pfirrmann (1-5) scale, and other degenerative changes (herniation, endplate defects, marrow signs, spinal stenosis) as binary present/absent.
Results Severe degenerative changes were significantly more prevalent in discs of symptomatics than asymptomatics in the lower (L4-S1) but not the upper (L1-L3) lumbar discs in subjects <60years. We found high co-existence of several degenerative features in both populations. Degeneration was minimal in around 30% of symptomatics < 50years.
Conclusions Automated MRI provides a valuable means of rapidly comparing large MRI datasets. Here, through directly comparing MRI annotations on the same objective scales it enabled us to detect significant age and spinal-level related differences in the prevalence of degenerative features between asymptomatic and symptomatic populations. By distinguishing between symptomatics whose discs have structural defects, and symptomatics with minimal degenerative changes, MRI could provide a means of clinical stratification, and provide a useful pathway to investigate possible pain sources.
What is already known about this subject?
Even though intervertebral disc degeneration, and degenerative changes such as disc herniations, are strongly associated with low back pain, the importance of disc degeneration in development of low back pain is questioned because these degenerative changes are seen in both those with and those without low back pain; spinal MRIs are thus thought to be of little clinical value.
What does this study add?
The study provides the first data on age-related degeneration in those without pain and shows the significant differences in prevalence between age-related and symptom-related disc degeneration.
The study provides definitive data showing that severe disc degeneration is directly implicated in a significant proportion of those with chronic low back pain, with the association with pain strongly dependent on age and spinal level
How might this impact on clinical practice or future developments?
The study shows that even though severe disc degeneration is strongly associated with low back pain, 30% of younger (<50yrs) chronic low back pain patients have no evident disc degeneration detected by MRI, which is important information (currently not used) for clinicians in directing treatments (and perhaps a clearer reason for the proper use of scans).
The study provides important information for those working on mechanisms, as it enables stratification between pathways of pain arising from structural defects in the disc, and those pain pathways in discs with no such structural change.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by: ☐ None OSCLMRIC Data collection Back to Back Charity (1079089) License income from Oswestry Disability Index via MAPI Research Trust to Back to BackMade to charity Back to Back TwinsUKLicense fee paid to KCL EPSRC Programme Grant Seebibyte (EP/M013774/1)Payment to Institution ECFP7 Project GENODISC (HEALTH-F2-2008-201626)Payment to Institution TwinsUK: Wellcome Trust; European Community 7th Framework Programme (FP7/2007-2013)Payment to Institution Payments were made to institutions in all cases
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Oxford is the sponsor of this research, in keeping with the requirements of the UK Policy Framework for Health and Social Care Research 2017. Health Research Authority approval for receipt and analysis of anonymised retrospective patient data was received in 2016 (project reference 207858).
August 25th 2016
Title Oxford Secondary Care Lumbar MRI Cohorts (OSCLMRIC) to assist in the development of an image analysis methodology to analyse clinical MRI studies in subjects with low back pain syndromes and asymptomatic controls.
PID 12139
Protocol Number 12139. Date/version 23/08/2016; v9.0;
Minor amendments ( to increase scope of recruitment and duration) were requested 18th March 2019) All the subjects in this report had been recruited before this date.
IRAS Project ID:
207858
REC Reference:
16/HRA/4532
Short Study Title:
Oxford Secondary Care Lumbar MRI Cohorts (OSCLMRIC)
Date complete amendment submission received:
18th March 2019
Sponsor Amendment Reference Number: NSA 1 - change of secondary objective, increase of sample size, extension of study duration, etc
Sponsor Amendment Date: 18 March 2019
Amendment Type: Non-Substantial
Outcome of HRA and HCRW Assessment:
HRA and HCRW Approval for the amendment is pending. HRA and HCRW Approval for the amendment will be separately confirmed by email.
Implementation date in NHS organisations in England and Wales:
35 days from date amendment information together with this email, is supplied to participating organisations (provided HRA and HCRW Approval is in place and conditions are met)
For NHS/HSC R&D Office information
Amendment Category
A
See email I have sent you dated 1st April 2019
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
